Ask AI
ProCE Banner Activity

Interactive Treatment Decision Tool for SCLC: Expert Guidance on Treatment

Tool

Use this Interactive Decision Support Tool to receive treatment recommendations from 5 experts for patients with Limited Stage and Extended-Stage SCLC.

Released: November 26, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education
 
ProCE Banner

Supporters

Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Jazz Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.

Disclosure

Primary Author

Anne Chiang, MD, PhD, FASCO: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Fosun, Genentech, Janssen, Jazz, Merck, Zai Lab; researcher: AbbVie, Amgen, AstraZeneca, Genentech.

Carl M. Gay, MD, PhD: consultant/advisor/speaker: Abdera, Amgen, AstraZeneca, BeOne, BioNTech, Boehringer Ingelheim, Daiichi Sankyo, Jazz, Merck, OncoHost, Roche/Genentech.

Ticiana Leal, MD: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Catalyst, Genentech, Gilead, Jazz, Johnson & Johnson, Merck, Molecular Partners, Naterra, Novocure, Pfizer, Regeneron, Roche, Sanofi, Summit, Synthekine.

Daniel Morgensztern, MD: consultant/advisor/speaker: AbbVie, Bayer, Bristol Myers Squibb, Johnson & Johnson/Janssen, Natera, Tubulis; researcher (paid to institution): AbbVie, AstraZeneca, Bristol Myers Squibb, Celgene, EpicentRx, Merck, Pfizer.

Mark A. Socinski, MD: consultant/advisor/speaker: AstraZeneca, BeiGene, Genentech, Guardant, Janssen, Jazz, Lilly, Regeneron, Spectrum, Summit; researcher (paid to institution): AstraZeneca, BeiGene, Cullinen, Enliven, Genentech.